112 related articles for article (PubMed ID: 7438330)
21. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological disposition of 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate in the dog.
Lu K; Loo TL
Cancer Res; 1980 May; 40(5):1427-30. PubMed ID: 7370981
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
24. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
25. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
28. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in mouse, dog, and monkey.
King FG; Dedrick RL
Cancer Treat Rep; 1979; 63(11-12):1939-47. PubMed ID: 118803
[TBL] [Abstract][Full Text] [Related]
30. Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dog.
Brodfuehrer JI; Wilke TJ; Kinder DH; Powis G
Cancer Chemother Pharmacol; 1989; 24(5):277-83. PubMed ID: 2758557
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent.
Tatsuta N; Suzuki N; Mochizuki T; Koya K; Kawakami M; Shishido T; Motoji N; Kuroiwa H; Shigematsu A; Chen LB
Cancer Chemother Pharmacol; 1999; 43(4):295-301. PubMed ID: 10071980
[TBL] [Abstract][Full Text] [Related]
33. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
35. Clinical and clinical pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728).
Stewart JA; Ackerly CC; Myers CF; Newman RA; Krakoff IH
Cancer Chemother Pharmacol; 1986; 16(3):287-91. PubMed ID: 2938841
[TBL] [Abstract][Full Text] [Related]
36. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
Frantz SW; Ballantyne B; Leung HW
Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
38. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
39. Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration.
Midgley I; Hood AJ; Proctor P; Chasseaud LF; Irons SR; Cheng KN; Brindley CJ; Bonn R
Xenobiotica; 1994 Jan; 24(1):79-92. PubMed ID: 8165824
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans.
Bühring KU; Sailer H; Faro HP; Leopold G; Pabst J; Garbe A
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S21-8. PubMed ID: 2439794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
